Yong Xie1, Gary S Mintz2, Junqing Yang3, Hiroshi Doi3, Andrés Iñiguez4, George D Dangas5, Patrick W Serruys6, John A McPherson7, Bertil Wennerblom8, Ke Xu2, Giora Weisz3, Gregg W Stone3, Akiko Maehara9. 1. Division of Cardiology, Columbia University Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Department of Cardiology, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, China. 2. Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. 3. Division of Cardiology, Columbia University Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. 4. Interventional Cardiology Unit, Hospital Meixoeiro, Vigo, Spain. 5. Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York. 6. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands. 7. Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. 8. Cardiology Department, Sahlgrenska University Hospital, Göteborg, Sweden. 9. Division of Cardiology, Columbia University Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. Electronic address: amaehara@crf.org.
Abstract
OBJECTIVES: The aim of this study was to report the frequency, patient and lesion-related characteristics, and outcomes of subclinical, nonculprit plaque ruptures in the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study. BACKGROUND: Plaque rupture and subsequent thrombosis is the most common cause of acute coronary syndrome (ACS). Secondary, subclinical, nonculprit plaque ruptures have been seen in both stable patients and patients with ACS; however, reports of the natural history of these secondary plaque ruptures are limited. METHODS: After successful stenting in 697 patients with ACS, 3-vessel grayscale and intravascular ultrasound virtual histology (IVUS-VH) was performed in the proximal-mid segments of all 3 coronary arteries as part of a prospective multicenter study. RESULTS: Among 660 patients with complete IVUS data, 128 plaque ruptures were identified in 105 nonculprit lesions in 100 arteries from 93 patients (14.1%). Although the minimum lumen area (MLA) was similar, the plaque burden was significantly greater in nonculprit lesions with a plaque rupture compared with nonculprit lesions without a plaque rupture (66.0% [95% confidence interval: 64.5% to 67.4%] vs. 56.0% [95% confidence interval: 55.6% to 56.4%]; p < 0.0001). IVUS-VH analysis revealed that a nonculprit lesion with a plaque rupture was more often classified as a fibroatheroma than a nonculprit lesion without a plaque rupture (77.1% vs. 51.4%; p < 0.0001). Independent predictors of a plaque rupture were lesion length (per 10 mm; odds ratio: 1.30; p < 0.0001), plaque burden at the MLA site (per 10%; odds ratio: 2.56; p < 0.0001), vessel area at the MLA site (per 1 mm(2); odds ratio: 1.13; p < 0.0001), and VH-thin-cap fibroatheroma (odds ratio: 1.80; p = 0.016). During 3 years of follow-up, the incidence of overall major adverse cardiac events did not differ significantly between the patients with and patients without subclinical, nonculprit plaque ruptures. CONCLUSIONS: Secondary, nonculprit plaque ruptures were seen in 14% of patients with ACS and were associated with a fibroatheroma phenotype with a residual necrotic core but not with adverse outcomes if patients were treated with optimal medical therapy as part of a multicenter study. (Providing Regional Observations to Study Predictors of Events in the Coronary Tree [PROSPECT]; NCT00180466).
OBJECTIVES: The aim of this study was to report the frequency, patient and lesion-related characteristics, and outcomes of subclinical, nonculprit plaque ruptures in the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study. BACKGROUND: Plaque rupture and subsequent thrombosis is the most common cause of acute coronary syndrome (ACS). Secondary, subclinical, nonculprit plaque ruptures have been seen in both stable patients and patients with ACS; however, reports of the natural history of these secondary plaque ruptures are limited. METHODS: After successful stenting in 697 patients with ACS, 3-vessel grayscale and intravascular ultrasound virtual histology (IVUS-VH) was performed in the proximal-mid segments of all 3 coronary arteries as part of a prospective multicenter study. RESULTS: Among 660 patients with complete IVUS data, 128 plaque ruptures were identified in 105 nonculprit lesions in 100 arteries from 93 patients (14.1%). Although the minimum lumen area (MLA) was similar, the plaque burden was significantly greater in nonculprit lesions with a plaque rupture compared with nonculprit lesions without a plaque rupture (66.0% [95% confidence interval: 64.5% to 67.4%] vs. 56.0% [95% confidence interval: 55.6% to 56.4%]; p < 0.0001). IVUS-VH analysis revealed that a nonculprit lesion with a plaque rupture was more often classified as a fibroatheroma than a nonculprit lesion without a plaque rupture (77.1% vs. 51.4%; p < 0.0001). Independent predictors of a plaque rupture were lesion length (per 10 mm; odds ratio: 1.30; p < 0.0001), plaque burden at the MLA site (per 10%; odds ratio: 2.56; p < 0.0001), vessel area at the MLA site (per 1 mm(2); odds ratio: 1.13; p < 0.0001), and VH-thin-cap fibroatheroma (odds ratio: 1.80; p = 0.016). During 3 years of follow-up, the incidence of overall major adverse cardiac events did not differ significantly between the patients with and patients without subclinical, nonculprit plaque ruptures. CONCLUSIONS: Secondary, nonculprit plaque ruptures were seen in 14% of patients with ACS and were associated with a fibroatheroma phenotype with a residual necrotic core but not with adverse outcomes if patients were treated with optimal medical therapy as part of a multicenter study. (Providing Regional Observations to Study Predictors of Events in the Coronary Tree [PROSPECT]; NCT00180466).
Authors: Liang Wang; Zheyang Wu; Chun Yang; Jie Zheng; Richard Bach; David Muccigrosso; Kristen Billiar; Akiko Maehara; Gary S Mintz; Dalin Tang Journal: Ann Biomed Eng Date: 2014-09-23 Impact factor: 3.934
Authors: Tomoyo Sugiyama; Erika Yamamoto; Krzysztof Bryniarski; Lei Xing; Hang Lee; Mitsuaki Isobe; Peter Libby; Ik-Kyung Jang Journal: JAMA Cardiol Date: 2018-03-01 Impact factor: 14.676
Authors: Hazel Arfah Haley; Mina Ghobrial; Paul D Morris; Rebecca Gosling; Gareth Williams; Mark T Mills; Tom Newman; Vignesh Rammohan; Giulia Pederzani; Patricia V Lawford; Rodney Hose; Julian P Gunn Journal: Front Cardiovasc Med Date: 2021-10-22
Authors: Thorsten Derlin; Daniel G Sedding; Jochen Dutzmann; Arash Haghikia; Tobias König; L Christian Napp; Christian Schütze; Nicole Owsianski-Hille; Hans-Jürgen Wester; Saskia Kropf; James T Thackeray; Jens P Bankstahl; Lilli Geworski; Tobias L Ross; Johann Bauersachs; Frank M Bengel Journal: Eur J Nucl Med Mol Imaging Date: 2018-07-03 Impact factor: 9.236